Supernus Pharmaceuticals, Inc. (SUPN): 25-NSE filed Nov 2, 2026

Form type

25-NSE

Filing date

Nov 2, 2026

Accession number

0001354457-26-001045

Filer

Supernus Pharmaceuticals, Inc. (CIK 1356576)